IRIS
OYEN, Willem Jozef Gerard
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.459
AS - Asia 11.592
EU - Europa 4.982
SA - Sud America 2.455
AF - Africa 1.086
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 19
Totale 58.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.046
SG - Singapore 8.439
BR - Brasile 2.212
CN - Cina 1.712
FI - Finlandia 1.367
IE - Irlanda 1.055
NG - Nigeria 913
FR - Francia 575
DE - Germania 565
NL - Olanda 394
HK - Hong Kong 380
GB - Regno Unito 336
CA - Canada 293
IT - Italia 244
TR - Turchia 163
IN - India 144
VN - Vietnam 126
BD - Bangladesh 104
IL - Israele 97
SE - Svezia 97
RU - Federazione Russa 88
AR - Argentina 75
IQ - Iraq 71
MX - Messico 62
ZA - Sudafrica 59
JP - Giappone 51
UA - Ucraina 45
ES - Italia 41
PL - Polonia 39
PK - Pakistan 37
UZ - Uzbekistan 37
AU - Australia 34
VE - Venezuela 31
IR - Iran 30
MA - Marocco 30
CL - Cile 29
CO - Colombia 28
EC - Ecuador 27
SA - Arabia Saudita 27
KE - Kenya 23
AE - Emirati Arabi Uniti 22
JO - Giordania 21
PY - Paraguay 20
CZ - Repubblica Ceca 19
ID - Indonesia 19
TN - Tunisia 19
AZ - Azerbaigian 17
EG - Egitto 17
NP - Nepal 17
AT - Austria 14
JM - Giamaica 14
A2 - ???statistics.table.value.countryCode.A2??? 13
LB - Libano 13
PE - Perù 13
RO - Romania 13
NZ - Nuova Zelanda 12
KZ - Kazakistan 11
BE - Belgio 10
BO - Bolivia 10
DZ - Algeria 10
CH - Svizzera 9
DO - Repubblica Dominicana 9
GR - Grecia 9
OM - Oman 9
PA - Panama 9
UY - Uruguay 9
HN - Honduras 8
LT - Lituania 8
MD - Moldavia 8
DK - Danimarca 7
RS - Serbia 7
SN - Senegal 7
MY - Malesia 6
NO - Norvegia 6
PS - Palestinian Territory 6
AL - Albania 5
BB - Barbados 5
BH - Bahrain 5
XK - ???statistics.table.value.countryCode.XK??? 5
TW - Taiwan 4
BG - Bulgaria 3
CR - Costa Rica 3
NI - Nicaragua 3
PH - Filippine 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
LI - Liechtenstein 2
LK - Sri Lanka 2
MN - Mongolia 2
PT - Portogallo 2
QA - Qatar 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 58.613
Salva come PNG Salva come JPEG
Città #
Chandler 7.378
Wilmington 6.853
San Mateo 2.586
Singapore 2.548
The Dalles 2.224
Ann Arbor 1.402
Shanghai 1.378
Helsinki 1.365
Leawood 1.222
Lawrence 1.117
Princeton 1.117
Dublin 1.050
Boardman 1.009
Benin City 911
Ashburn 754
Fairfield 684
Woodbridge 647
New York 624
Dallas 615
Paris 556
Amsterdam 376
Seattle 362
Hong Kong 358
San Diego 315
Beijing 231
London 229
Toronto 206
São Paulo 183
Los Angeles 129
Norwalk 128
Kocaeli 103
Milan 103
Rio de Janeiro 75
Belo Horizonte 68
Santa Clara 67
Phoenix 59
Falkenstein 53
Brooklyn 52
Ho Chi Minh City 51
Houston 41
Tokyo 40
Chicago 39
Pune 39
Brasília 38
Porto Alegre 35
Tashkent 33
Montreal 32
Dhaka 31
Moscow 31
Reston 31
Johannesburg 30
Monmouth Junction 30
Munich 30
Redmond 29
Campinas 28
Warsaw 27
Boston 26
Des Moines 26
Curitiba 25
Stockholm 25
Baghdad 22
Hanoi 22
Istanbul 21
Council Bluffs 20
Salvador 20
Amman 19
Ribeirão Preto 19
Charlotte 18
San Francisco 18
Chennai 17
Fortaleza 17
Nairobi 17
Denver 15
Guarulhos 15
Hangzhou 15
Baku 14
Cambridge 14
Clearwater 14
Erbil 14
Goiânia 14
Juiz de Fora 14
Manchester 14
Mexico City 14
Naples 14
Sorocaba 14
Asunción 13
Caracas 13
Hanover 13
Manaus 13
New Delhi 13
Orem 13
São José dos Campos 13
Andover 12
Atlanta 12
Caxias do Sul 12
Contagem 12
Maringá 12
Redwood City 12
Viamão 12
Volta Redonda 12
Totale 40.456
Salva come PNG Salva come JPEG
Nome #
(18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses. 103
18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice 99
2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study 94
18F-FLT-PET for the evaluation of MEK inhibitor AZD6244 85
[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer 85
Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor 84
The Role of FDG-PET in the Assessment of Thyroid Nodules with an Indeterminant or Suspicious Cytologic Diagnosis 84
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients 84
F-18-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation 83
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 82
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 81
F-18-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis 81
New targeted probes for radioimaging of angiogenesis 81
F-18-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients 81
F-18-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis 81
Effect of the positron range on the spatial resolution of a new generation pre-clinical PET using fluorine-18, gallium-68, zirconium-89 and iodine-124 80
F-18-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis 80
[F-18]-Fluorination of a Leukotriene B4 Receptor Antagonist via Hydrazone Formation and its Application in Infection Imaging 80
PET-CT for response assessment and treatment adaptation in head and neck cancer 78
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis 78
F-18-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality 78
18F-FDG PET/CT in Detecting Metastatic Infection in Children 77
[F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma 77
3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients 77
Kidney protection during peptide receptor radionuclide therapy (PRRT) 76
Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study 76
Radioimmunotherapy with I-131-cG250 monoclonal antibody in patients with metastasized RCC, a phase I/II study. 76
99mTc-interleukin-8 for imaging acute osteomyelitis 76
F-18-FDG PET AS A PREDICTOR OF PULMONARY FUNCTION IN SARCOIDOSIS 76
7TH ANNUAL-MEETING OF THE INTERNATIONAL RESEARCH GROUP IN IMMUNOSCINTIGRAPHY AND IMMUNOTHERAPY 75
Comparison of liver SUV using unenhanced CT versus contrast- enhanced CT for attenuation correction in 18 F-FDGPET/CT 75
F-18-FDG PET of thyroid nodules with inconclusive cytologic results - Reply 75
Background-subtracted optimal threshold segmentation algorithm for FDG-PET based GTV delineation: Theory and experimental validation 75
[F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier 75
The role of megalin in the renal uptake of radiolabeled peptides 74
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer 74
A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci 74
Megalin Plays an Important Role in the Renal Uptake of Various Radiolabeled Peptides: Studies in Megalin-Deficient Mice 74
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 74
INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 73
F-18-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia 73
Clinical application of FDG-PET/CT in metastatic infections 73
A 3-step pretargeting strategy to image infection 73
18F-FDG-PET reduces the number of direct laryngoscopies in patients with suspected recurrent laryngeal carcinoma after radiotherapy 73
SPECT/CT-based Dosimetry for a Multicentre Trial of Selumetinib Enhanced Radioiodine Treatment of Differentiated Thyroid Cancer: Preliminary Results 72
Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo 72
Dynamic FDG PET in liver metastases of colorectal cancer: repeatability of dynamic and static FDG PET parameters. 72
WHICH FACTORS PREDICT THE RESULTS OF PITUITARY SURGERY IN ACROMEGALY 72
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer 72
Albumin derived peptides efficiently reduce renal uptake of radiolabeled peptides 71
Pretargeted immuno-PET imaging and radioimmunotherapy of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody 71
CAN FOG-PET PREDICT RADIATION TREATMENT OUTCOME IN HEAD AND NECK CANCER? 71
Evaluation of the advanced ReSPECT image reconstruction software in a phantom model and in parathyroid scanning 71
FDG-PET and CT in the staging of melanoma patients with lymph node metastases; diagnostic performance and clinical consequences 71
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: Report of a case 71
Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review 71
Ga-68-labelled exendin-3, a new agent for the detection of insulinomas with PET 71
Reducing renal uptake of radiolabeled peptides using albumin fragments 70
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors 70
INDIUM-111-LABELED HUMAN NONSPECIFIC IMMUNOGLOBULIN-G - A NEW RADIOPHARMACEUTICAL FOR IMAGING INFECTIOUS AND INFLAMMATORY FOCI 70
EANM Focus 1: one small step for two men, one giant leap for a specialty 70
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer 70
Spatial resolution of the Inveon small-animal PET scanner for the entire field of view 70
In-111-anti-F4/80 for in vivo tracking of tumor associated macrophages 70
SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA 69
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 69
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 69
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss 69
Molecular Imaging and Theranostics-A Multidisciplinary Approach 69
F-18-FDG PET/CT in Local Ablative Therapies: A Systematic Review 69
Radiopharmaceuticals to image infection and inflammation 69
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy 69
Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody 69
Validated image fusion of dedicated PET and CT for external beam radiation therapy in the head and neck area 69
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma 69
F-18-fluorodeoxyglucose positron emission tomography of colonic anastomosis: A possibility to detect anastomotic leakage? A pilot study 69
RADIOIMMUNOCONJUGATES IN THE DETECTION OF INFECTION AND INFLAMMATION 69
PET and SPECT Imaging of a Radio labeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with Cu-64, Ga-68, and In-111 69
SPECIFIC ANTIBODY UPTAKE IN TUBERCULOSIS 68
In-111-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib 68
Radiolabeled IL-1ra for detection of synovitis in patients with RA. Preliminary results. 68
Macrophage targeting in experimental arthritis 68
FDG-PET in diagnosing central venous catheter related infection in stem cell transplant recipients 68
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET 68
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using Ga-68-RGD PET/CT 68
IMPROVED SELECTION OF PATIENTS FOR HEPATIC SURGERY OF COLORECTAL LIVER METASTASES WITH FDG-PET: RESULTS OF THE RANDOMIZED DUTCH POLEM STUDY 67
Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer 67
Molecular imaging of hypoxia 67
Progress in nuclear medicine procedures in head and neck oncology 67
Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring 67
Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT 67
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring F-18-FDG PET studies 67
LOCALIZATION OF INFECTION IN HIV ANTIBODY-POSITIVE PATIENTS WITH FEVER - COMPARISON OF THE EFFICACY OF GA-67-CITRATE AND RADIOLABELED HUMAN-IGG 67
A modelling approach to estimate the FDG arterial plasma time activity curve in Patlak-based therapy response analysis 66
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise 66
SUV: From Silly Useless Value to Smart Uptake Value 66
Zirconium-89-girentuximab PET/CT imaging in renal cell carcinoma: first in man results 66
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER 66
F-18-FDG PET in detecting metastatic infectious disease 66
Consensus on molecular imaging and theranostics in prostate cancer 66
Totale 7.341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 498.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 498.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.958 0 0 0 0 0 3.755 1.703 568 2.523 2.209 3 1.197
2021/20224.627 79 16 98 1.389 3 6 125 846 434 329 1.015 287
2022/202317.903 2.481 628 1.666 1.827 1.928 1.633 9 1.746 3.329 1.396 999 261
2023/20246.755 651 912 1.757 185 208 613 138 381 91 69 490 1.260
2024/20259.716 186 155 58 29 29 1.005 486 1.576 1.297 2.812 936 1.147
2025/20267.688 3.861 1.005 381 1.706 576 159 0 0 0 0 0 0
Totale 58.864